glp 1 and gut microbiome GLP-1 Medicines Bacterial Overgrowth Gut microbiome depletion abolishes postprandial
Description
Example: If a patient started therapy at BMI 37 and now has BMI 31 after successful treatment, the provider may attest to the BMI at initiation if documented appropriately

B12 and nausea reduction Nausea is the most common side effect of GLP-1 and GLP-1/GIP receptor agonists

The GLP-1 Support Pack helps support: Nutrient needs when food intake drops Digestive comfort and gut balancee Energy, metabolism, bone, and muscle health WHY IT MATTERS If you don't feel good, you won't stay consistent

However, it's essential to note that individual responses to medications may vary

Semaglutide is FDA approved to help reduce the risk of serious cardiovascular events, including heart attacks, strokes, and cardiovascular death, in people with established heart disease who are overweight or obese

it does not predict exact medication response or replace medical evaluation
